Will Caron currently serves as the Director of Financial Planning and Analysis at Oculis, a position held since January 2024. Previously, Will held similar leadership roles at CRISPR Therapeutics and Translate Bio, where responsibilities included directing financial planning and analysis efforts. Will's career spans multiple positions in financial management across various organizations, including Aegerion Pharmaceuticals, TeleTech Insights, and PAREXEL, where significant contributions included enhancing financial processes, creating performance metrics, and ensuring compliance with corporate policies. Will's educational background includes a degree from Northeastern University.
This person is not in any teams
This person is not in any offices